The Glucose Clamp technique is a useful tool in the development of anti-diabetic medications. It allows the measurement of highly precise whole-body and organ-specific insulin sensitivity, the determination of predefined blood glucose concentrations and the characterization of the blood glucose properties of almost any anti-diabetic drug with respect to its time-action profile.
We offer extensive experience in diabetes research, recognized recruitment capabilities and industry leading scientific leadership to support the planning and execution of hyperglycemic, hyperinsulinemic, euglycemic and pancreatic Glucose Clamp Studies.
Favorable demographics in North Carolina
6000+ Diabetics in our database
Proactive pre-screening initiatives collecting relevant data: medical history, treatment regiment, blood glucose levels and HbA1c, CAP scores
“If you have worked in the Metabolic disorders space or for a biopharmaceutical company focusing on the development of treatments for Diabetes, obesity or Fatty liver, there is a high probability that you’ve encountered the term ‘glucose clamps.’ At their core, glucose clamps are infusion-based tests that in some way interrupt the insulin-glucose feedback loop.”